Association between thrombus composition and first pass recanalization after thrombectomy in acute ischemic stroke.

Ischemic stroke thrombectomy thrombosis

Journal

Journal of thrombosis and haemostasis : JTH
ISSN: 1538-7836
Titre abrégé: J Thromb Haemost
Pays: England
ID NLM: 101170508

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 10 04 2024
revised: 27 05 2024
accepted: 30 05 2024
medline: 20 6 2024
pubmed: 20 6 2024
entrez: 19 6 2024
Statut: aheadofprint

Résumé

Achieving first pass recanalization (FPR) has become the primary procedural objective during thrombectomy in acute ischemic stroke patients as it correlates with the best clinical outcome. Understanding factors contributing to FPR failures is essential to enhance FPR success rates. As the central target of thrombectomy, the thrombus itself may be a significant factor influencing FPR. This study aims to investigate the association between thrombus composition and FPR success rates. In total, thrombi from 267 ischemic stroke patients were collected in the AZ Groeninge Hospital (Kortrijk, Belgium). Thrombus composition was determined via detailed histological analysis of red blood cells (RBC), fibrin, von Willebrand factor, platelets, leukocytes, citrullinated histone 3 (marker for neutrophil extracellular traps) and intra- and extracellular DNA. FPR was defined as obtaining a modified Thrombolysis in Cerebral Ischemia (mTICI) score of 2c/3 after the first pass. An mTICI score of 2c/3 was obtained in 180 patients, which was achieved via a successful FPR procedure in 126 cases or after multiple passes in 54 cases. Interestingly, thrombi from FPR cases had a different composition than thrombi that needed multiple passes to obtain mTICI 2c/3. FPR thrombi contained significantly more RBC (p=0.0264), less fibrin (p=0.0196) and less extracellular DNA (p=0.0457). Our results indicate that thrombi characterized by lower RBC content, higher fibrin levels, and increased extracellular DNA are less likely to result in a FPR. These results are important to guide future research aiming at improving procedures or technologies to obtain FPR-rates in RBC-poor thrombi.

Identifiants

pubmed: 38897388
pii: S1538-7836(24)00357-X
doi: 10.1016/j.jtha.2024.05.034
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Sarah Vandelanotte (S)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Senna Staessens (S)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Olivier François (O)

: Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium.

Maaike De Wilde (M)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Linda Desender (L)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Anne-Sophie De Sloovere (AS)

: Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium.

Tom Dewaele (T)

: Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium.

Claudia Tersteeg (C)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Karen Vanhoorelbeke (K)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium.

Peter Vanacker (P)

: Department of Neurology, AZ Groeninge, Kortrijk, Belgium; : Department of Neurology, University Hospitals Antwerp, Antwerp, Belgium; : Department of Translational Neuroscience, University of Antwerp, Antwerp, Belgium.

Tommy Andersson (T)

: Departments of Neuroradiology, Karolinska University Hospital, and Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Simon F De Meyer (SF)

: Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium. Electronic address: simon.demeyer@kuleuven.be.

Classifications MeSH